You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Baxter
Moodys
Johnson and Johnson
Mallinckrodt

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pentastarch


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Pentastarch?

Pentastarch is an investigational drug.

There have been 5 clinical trials for Pentastarch. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.

The most common disease conditions in clinical trials are Shock, Shock, Traumatic, and Shock, Hemorrhagic. The leading clinical trial sponsors are Sangart, University of British Columbia, and Children's & Women's Health Centre of British Columbia.

Recent Clinical Trials for Pentastarch
TitleSponsorPhase
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock PatientsSangartPhase 2
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock PatientsSangartPhase 2
Fluid Resuscitation in Early Septic ShockBaxter Healthcare CorporationPhase 2

See all Pentastarch clinical trials

Clinical Trial Summary for Pentastarch

Top disease conditions for Pentastarch
Top clinical trial sponsors for Pentastarch

See all Pentastarch clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.